A carregar...
Dose-response study of ibandronate in the treatment of cancer-associated hypercalcaemia.
Hypercalcaemia is an important cause of morbidity in malignant disease. We studied the efficacy and safety of intravenous ibandronate (a new, potent bisphosphonate) in a multicentre study of 147 patients with severe cancer-associated hypercalcaemia which had been resistant to treatment with rehydrat...
Na minha lista:
Main Authors: | , , , , , , , , , , , |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Nature Publishing Group|1
1997
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2063262/ https://ncbi.nlm.nih.gov/pubmed/9010041 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|